ArticleACS omega2025
Innovative Process for the Recovery of Oleuropein-Rich Extract from Olive Leaves and Its Biological Activities: Encapsulation for Activity Preservation with Concentration Assessment Pre and Post Encapsulation.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Enhancing the Phenolic Value of Polyphenol-Rich Extra Virgin Olive Oils Through Optimized Water Extraction, Macroporous Resin Recovery and Spray Drying.Molecules (Basel, Switzerland) · 2026Article
- Valorization of Olive Pomace as a Source of Phenolic Compounds: Extraction Technologies, Analytical Characterization, Biological Activities, and Food Applications.Foods (Basel, Switzerland) · 2026Review
- A comprehensive review ofRSC advances · 2026Review
- Microwave-Assisted Rapid Extraction of Oleuropein from Olive Leaf By-Product and Processing into Oleuropein@Zeolite Nanohybrids for Antioxidant Food Applications (Fortified Salt and Active Gelatin Films).Molecules (Basel, Switzerland) · 2026Article
- Valorization of Olive Leaf Extract via Tailored Liposomal Carriers: Comparative Analysis of Physicochemical Features, Antioxidant Capacity, and Stability.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Pharmacognosy and Antioxidant Activity of Pruned Leaves from the UnexploredMolecules (Basel, Switzerland) · 2025Article
- Antioxidant Nanohybrid Materials Derived via Olive Leaf Extract Incorporation in Layered Double Hydroxide: Preparation, Characterization, and Evaluation for Applications.Antioxidants (Basel, Switzerland) · 2025Article
- Comparative Evaluation of Takhrai (Veterinary sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olive leaves, often regarded as agricultural and industrial waste, hold significant potential for economic and medicinal applications. This study examines the valorization of olive leaves through the extraction of phenolic compounds, notably oleuropein and hydroxytyrosol, using autoclave extraction techniques. It also investigates encapsulation techniques employing maltodextrin and sodium caseinate as wall materials to preserve the stability and bioavailability of these compounds. The results indicate a rich phenolic profile in the nonencapsulated olive leaf extract (OLE), demonstrating high antioxidant and antibacterial activities against various pathogens. The encapsulation process achieved high efficiency with a mixture of maltodextrin and sodium caseinate. Furthermore, FTIR spectroscopy and NMR analyses confirmed the presence of functional groups in the encapsulated extract, providing insight into its molecular structure. Overall, this study underscores the potential of olive leaves as a valuable source of bioactive compounds and highlights the importance of innovative extraction and encapsulation techniques to optimize their use across different applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.